Status:

TERMINATED

L-C Ligament Versus Hamstring Autograft for Primary ACL Reconstruction

Lead Sponsor:

Soft Tissue Regeneration, Inc.

Conditions:

Acute Ruptures of the Anterior Cruciate Ligament

Eligibility:

All Genders

18-45 years

Phase:

PHASE2

PHASE3

Brief Summary

The purpose of this study is to compare safety and efficacy outcomes of the L-C Ligament versus Hamstring Autograft for treatment of acute rupture of the ACL.

Eligibility Criteria

Inclusion

  • Patients with acute ruptures of the ACL who are willing to undergo treatment within 18 weeks of injury

Exclusion

  • Prior ACL reconstruction or other surgical procedure on the affected (target) knee
  • Chronic ACL injury; interventional surgery scheduled 127 days or more after ACL injury
  • Professional athletes currently engaged in active sport
  • Prior distal femoral and/or proximal tibial fracture(s) of the target leg
  • Previous or current ACL injury on contra-lateral leg
  • Multi-ligament reconstruction
  • Malalignment or varus thrust
  • Patient \> 193 cm tall (6' 4")
  • The patient does not follow pre-operative rehabilitation that may have been prescribed post-injury (prior to Index Procedure)
  • Confirmed connective tissue disorder
  • Signs of moderate to severe degenerative joint disease
  • Severe pain, swelling, or redness within 24 hours prior to surgery
  • Complete or partial Posterior Cruciate Ligament (PCL) tear
  • If concomitant meniscal injury is present, any of the following: 1/3rd meniscal resection; complex double-bucket tear; partially repaired meniscal tears
  • Any type of lateral and/or medial meniscal tear which is not repairable (\<2mm from rim)
  • Additional concomitant injuries to the knee or lower extremities requiring treatment, per surgeon's discretion, that are not allowable under the Inclusion criteria
  • The patient is unwilling to not participate in sporting activities for at least 9 months post-procedure
  • The patient is mentally compromised
  • The patient has a neuromuscular disorder that would engender unacceptable risk of knee instability, prosthesis fixation failure, or complications in postoperative care
  • The patient has an active or latent infection in or about the affected knee joint or an infection site distant from the knee that may spread to the knee hematogenously
  • Pregnant based on a positive beta hCG serum or an in vitro diagnostic test result or breast-feeding
  • The patient is obese with a BMI \> 35
  • The patient has a known allergy to PLLA
  • The patient has a medical condition or comorbidity that would interfere with study participation

Key Trial Info

Start Date :

September 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2020

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT02183727

Start Date

September 1 2015

End Date

July 1 2020

Last Update

November 22 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Isala Klinieken

Zwolle, Netherlands